VIDA Diagnostics

29 articles about VIDA Diagnostics

• VIDA Launches VIDA Intelligence Portal 2.0 to Accelerate Onboarding of Clinical Trial Sites

  11/28/2022

  VIDA Diagnostics, Inc. (VIDA), the leader in imaging intelligence, has announced the availability of VIDA Intelligence Portal 2.0, a major upgrade of its cloud native, AI-enabled Intelligence platform.

• VIDA Introduces New AI-Enabled Biomarker Services

  5/15/2022

  VIDA Diagnostics, Inc., the leader in lung and respiratory intelligence data, is introducing a new suite of retrospective data analysis services for clinical trial sponsors in response to growing demand for precision data to optimize lung treatment trials.

• Strong Demand for Lung Intelligence Accelerates VIDA's Growth

  5/4/2022

  VIDA Diagnostics, Inc., the leader in lung and respiratory intelligence, announced it has secured financing as it scales up to support strong demand for its VIDA Intelligence Portal, an AI-powered solution that supports clinical trial decentralization and improves site recruitment, onboarding, staff training, image data management and data quality.

• OSF HealthCare advances innovative patient care using VIDA Insights® lung intelligence solution

  5/11/2021

  Strategic partnership with OSF HealthCare underscores VIDA's ongoing dedication to raising the standard of care for patients with lung and respiratory diseases

• VIDA appoints digital health technology leader Karen Drexler to board of directors, underscoring focus on market expansion of AI solutions

  8/11/2020

  Growing bench of proven leaders in clinical lung intelligence and health technology bolsters both product and commercial advances

• Respiratory health AI trailblazer VIDA poised for increased scale with newest appointment to leadership team

  7/7/2020

  VIDA Diagnostics, Inc. ("VIDA"), the leader in AI-powered lung imaging analysis, announced today that Todd Johnson has joined the company as chief technology officer. Johnson, a leader in enterprise imaging and advanced clinical applications, will apply his expertise to extend the breadth and depth of VIDA's LungPrint® solutions

• VIDA Completes Second Close Of Round C Financing

  4/15/2020

  $2M Second Close from Strategic Partners Completes $13M C Round to Advance AI-Powered Respiratory Solutions

• VIDA Announces Series C Financing To Accelerate Access To AI-Powered Lung Imaging Analysis

  3/12/2020

  VIDA Diagnostics, Inc. ("VIDA"), the leader in AI-powered lung imaging analysis, today announced an $11M initial close of its Series C financing.

• VIDA Partners With TeraRecon, Inc. For Distribution Of AI-Powered Lung Analysis

  10/14/2019

  VIDA Diagnostics, Inc. ("VIDA"), the leader in AI-powered lung imaging analysis, announced a distribution agreement with TeraRecon, Inc., a leader in advanced visualization, artificial intelligence, image viewing, and post-processing

• VIDA Expands Board, Announcing Erkan Akyuz As Independent Director

  10/4/2019

  VIDA Diagnostics, Inc., the leader in AI-powered lung imaging analysis, announced the appointment of Erkan Akyuz as independent director.

• VIDA Announces Strategic Investment From UnityPoint Health Ventures

  7/25/2019

  $1M Investment Combined with Support from the State of Iowa Represents a Shared Vision to Transform Health Care through AI-Powered Innovation

• VIDA Joins Nuance AI Marketplace for Diagnostic Imaging To Deliver Lung Analytics Solutions to Radiologists and Care Teams

  6/25/2019

  VIDA's LungPrint® Discovery analysis will be available through the Nuance AI Marketplace to 70 percent of all radiologists across more than 6,000 connected healthcare facilities.

• VIDA Previews LungPrint™, An AI-Powered Lung Imaging Analytics Solution Launching At RSNA 2018

  11/14/2018

  VIDA Diagnostics ("VIDA"), the leader in pulmonary imaging analytics, announced it will launch LungPrint™ Discovery, an innovative AI-powered lung analysis solution for radiologists, at the Radiological Society of North America's (RSNA) 104th Scientific Assembly and Annual Meeting, November 25-30 in Chicago.

• VIDA Diagnostics Enriches Pulmonary Suite To Include Advanced COPD And Asthma Analysis

  9/11/2017

• VIDA Diagnostics Raises $5.1m In Round B Funding To Commercialize Precision Pulmonary Informatics Software And Services

  12/20/2016

• VIDA Diagnostics Expands Executive Team With Appointment Of Chief Operations Officer

  12/12/2016

• VIDA Diagnostics And Olympus Expand Strategic Partnership

  5/17/2016

• VIDA Diagnostics Brings Power Of Precision Imaging Directly To Pulmonologists With Release Of VIDA|Vision Clinical Software

  5/16/2016

• VIDA Diagnostics Wins Product Of Outstanding Interest Award For Precision Pulmonary Imaging Solution

  9/30/2015

• VIDA Diagnostics And Olympus Team Up For Delivery Of Quantitative Lung Imaging Services

  5/18/2015